Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yolanda Cancho Grande is active.

Publication


Featured researches published by Yolanda Cancho Grande.


Bioorganic & Medicinal Chemistry Letters | 2003

Pyrimidinone antibiotics--heterocyclic analogues with improved antibacterial spectrum.

Michael Brands; Yolanda Cancho Grande; Rainer Endermann; Reinhold Gahlmann; Jochen Krüger; Siegfried Raddatz

We report the synthesis and pharmacological evaluation of new derivatives of the natural dipeptide antibiotic TAN 1057 A,B containing heterocycles either in the beta-amino acid side chain or as mimics of the urea function. In the course of this program, we identified novel analogues that display activity towards a broader panel of Gram-positive bacteriae.


Archive | 2010

Substituted piperidines as par-1 antagonists

Mario Jeske; Dirk Heimbach; Susanne Röhrig; Yolanda Cancho Grande; Dirk Schneider; Ulrich Rester; Eckhard Bender; Mark Meininghaus; Katja Zimmermann; Dmitry Zubov; Anja Buchmüller; Georges Degenfeld; Christoph Gerdes; Michael Gerisch; Mark Jean Gnoth; Kersten Matthias Gericke


Archive | 2008

Substituted 6-phenylnicotinic acids and their use

Lars Baerfacker; Barbara Albrecht-Kuepper; Peter Kolkhof; Yolanda Cancho Grande; Adam Nitsche; Heinrich Meier; Carsten Schmeck; Jens Schamberger; Klemens Lustig


Archive | 2018

THIÉNO-URACILES À SUBSTITUTION N 3 -CYCLIQUE ET LEUR UTILISATION

Michael Härter; Dirk Kosemund; Yolanda Cancho Grande; Martina Delbeck; Bernd Kalthof; Klemens Lustig; Frank Süssmeier


Archive | 2017

PIPERIDINILPIRAZOLOPIRIMIDINONAS Y UTILIZACIÓN DE LAS MISMAS

Willem Jan Hengeveld; Jrg Heiermann; Matthias Werner; Joachim Schuhmacher; Christian Stegmann; Karl Schlemmer; Nils Burkhardt; Maria Kllnberger; Imke Meyer; Jan Stampfuss; Michael Sperzel; Susanne Dr Rhrig; Kristin Beyer; Johannes Kbberling; Tom Kinzel; Jorma Hassfeld; Yolanda Cancho Grande; Gaelle Valot; Manuel Ellermann


Archive | 2016

INDAZOLOPYRIMIDINONES AS FIBRINOLYSIS INHIBITORS

Manuel Ellermann; Gaelle Valot; Yolanda Cancho Grande; Jorma Hassfeld; Tom Kinzel; Johannes Köbberling; Kristin Beyer; Susanne Röhrig; Michael Sperzel; Jan Stampfuss; Imke Meyer; Maria Köllnberger; Nils Burkhardt; Karl-Heinz Schlemmer; Christian Stegmann; Joachim Schuhmacher; Matthias Werner


Archive | 2016

PIPERIDINYLPYRAZOLOPYRIMIDINONES AND THEIR USE

Manuel Ellermann; Gaelle Valot; Yolanda Cancho Grande; Jorma HAßFELD; Tom Kinzel; Johannes Köbberling; Kristin Beyer; Susanne Röhrig; Michael Sperzel; Jan STAMPFUß; Imke Meyer; Maria Köllnberger; Nils Burkhardt; Karl-Heinz Schlemmer; Christian Stegmann; Joachim Schuhmacher; Matthias Werner; Jörg Heiermann; Willem Jan Hengeveld


Archive | 2009

ACIDOS 6-FENILNICOTINICOS SUSTITUIDOS Y SU USO

Barbara Albrecht-Küpper; Lars Bärfacker; Peter Kolkof; Yolanda Cancho Grande; Adam Nitsche; Heinrich Meier; Carsten Schmeck; Jens Schamberger; Klemens Lustig


Archive | 2007

Substituted 2-phenylpyrimidine-5-carboxylic acids and their use

Barbara Albrecht-Küpper; Lars Bärfacker; Yolanda Cancho Grande; Peter Kolkhof; Klemens Lustig; Adam Nitsche


Archive | 2007

Substituierte 2-Phenylpyrimidin-5-carbonsäuren und ihre Verwendung Substituted 2-phenyl-pyrimidine-5-carboxylic acids and their use

Barbara Albrecht-Küpper; Lars Bärfacker; Yolanda Cancho Grande; Peter Kolkhof; Klemens Lustig; Adam Nitsche

Collaboration


Dive into the Yolanda Cancho Grande's collaboration.

Top Co-Authors

Avatar

Klemens Lustig

Bayer Schering Pharma AG

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Peter Kolkhof

Bayer Schering Pharma AG

View shared research outputs
Top Co-Authors

Avatar

Adam Nitsche

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Heinrich Meier

Bayer Schering Pharma AG

View shared research outputs
Top Co-Authors

Avatar

Christian Stegmann

Bayer HealthCare Pharmaceuticals

View shared research outputs
Researchain Logo
Decentralizing Knowledge